<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00439790</url>
  </required_header>
  <id_info>
    <org_study_id>0602508</org_study_id>
    <nct_id>NCT00439790</nct_id>
  </id_info>
  <brief_title>Sympathetic Nerve Activity and an Implantable Cardioverter Defibrillator in Heart Failure Patients</brief_title>
  <official_title>Validation of a Prognostic Score to Identify Heart Failure Patients Who Might Need an Implantable Cardioverter Defibrillator Using Muscle Sympathetic Nerve Activity and Autonomic Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to analyze whether the sympathetic tone, measured indirectly and&#xD;
      directly by muscle sympathetic nerve activity recording, is elevated in patients with heart&#xD;
      failure receiving an appropriate shock from their implantable cardiac defibrillator (ICD)&#xD;
      compared to heart failure patients not receiving a shock from their ICD. All parameters&#xD;
      measured in this study will be used to build a risk algorithm able to identify heart failure&#xD;
      patients at high risk for sudden cardiac death who could receive an ICD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We plan to perform an extensive study of the sympathetic nervous system activity in heart&#xD;
      failure patients with an ICD. The SNS activity will be measured directly by a recording of&#xD;
      the muscle sympathetic nerve activity and indirectly by post processing of 24-hour Holter&#xD;
      recording, catecholamine levels assessment, and spontaneous baroreflex sensitivity. A global&#xD;
      assessment of the patients status will also be realised. Patients will be followed for one&#xD;
      year. During follow up, this cohort will be divided into two groups according to the&#xD;
      occurrence or not of an appropriate shock. We assume that an appropriate shock is a surrogate&#xD;
      marker for sudden cardiac death. We plan to compare the autonomic nervous system activity in&#xD;
      both groups of patients in order to identify a score able to detect heart failure patients at&#xD;
      high risk for sudden cardiac death.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">109</enrollment>
  <condition>Heart Failure</condition>
  <condition>Death, Sudden, Cardiac</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microneurography</intervention_name>
    <description>Microneurography</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patient&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Heart failure patient with an ICD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant patient&#xD;
&#xD;
          -  Acute coronary syndrome within the last 3 months&#xD;
&#xD;
          -  Peripheral neuropathy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Atul Pathak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital University Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiologie, University Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>February 23, 2007</study_first_submitted>
  <study_first_submitted_qc>February 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2007</study_first_posted>
  <last_update_submitted>June 12, 2012</last_update_submitted>
  <last_update_submitted_qc>June 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>implantable cardioverter defibrillator</keyword>
  <keyword>Heart failure</keyword>
  <keyword>Sudden Cardiac Arrest</keyword>
  <keyword>appropriate shock</keyword>
  <keyword>Defibrillators, Implantable</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Death, Sudden</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

